A prospective cross sectional observational study on prevalence of clinical manifestations and hormonal abnormalities associated with polycystic ovarian disease

I.S.V. Manvita, G Sravani, M.Sudhakar, Malathi, B.Bhavani, Janvi Varma, Anusha, Ramya Uppala, Azmira Aktar
{"title":"A prospective cross sectional observational study on prevalence of clinical manifestations and hormonal abnormalities associated with polycystic ovarian disease","authors":"I.S.V. Manvita, G Sravani, M.Sudhakar, Malathi, B.Bhavani, Janvi Varma, Anusha, Ramya Uppala, Azmira Aktar","doi":"10.54037/wjps.2021.91211","DOIUrl":null,"url":null,"abstract":"Polycystic ovarian disorder (PCOD)isthe mostcommonhormonal disorder seenin females of reproductive worldwide. From the very limited data, PCOD prevalence in India ranges from 3.7% to 22.5%. Polycystic Ovarian disease requires \"control\" rather than \"cure\", the treatmentdecisions depend on symptoms, age, whether or not the women wantto becomepregnant.Aim: To study the prevalence of clinical manifestations andhormonal abnormalities associated with PCOD. Methodology: This prospective observational study was carried out in gynaecology department of Mallareddy hospital, where subjects were enrolled based on inclusion and exclusion criteria. All 100 patients demographics were documented. The prevalence of clinical manifestations and hormonal abnormalities in all subjects were assessed.Results: Irregular menstruation was seen as the most common clinical manifestation and seen in maximum 66% of subjects, Hirsutism was seen in 35% of the cases followed by acne in 28% of cases , androgenic alopecia in 22% of cases and acanthosis nigricans in minority 7% of cases .When the subjects were assessed for hormonal abnormalities, 52% of the subjects showed decreased FSH, 48% of the subjects had increased LH, 9% had decreased and33 % had increased PRL, 38% showed increased Testosterone, 21% had decreased and 7% had increased T3, T4 levels.Conclusion: Irregular menstruation was seen as the most common clinical manifestation followed by dermatologic manifestations –Hirsutism, Acne, Acanthosis nigricans and androgenic alopecia.Clinical manifestations diagnosis can lead to early treatment in these patients and helps them in relieving their symptoms and improve qualityof life.","PeriodicalId":23975,"journal":{"name":"World journal of Pharmacy and pharmaceutical sciences","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of Pharmacy and pharmaceutical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54037/wjps.2021.91211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Polycystic ovarian disorder (PCOD)isthe mostcommonhormonal disorder seenin females of reproductive worldwide. From the very limited data, PCOD prevalence in India ranges from 3.7% to 22.5%. Polycystic Ovarian disease requires "control" rather than "cure", the treatmentdecisions depend on symptoms, age, whether or not the women wantto becomepregnant.Aim: To study the prevalence of clinical manifestations andhormonal abnormalities associated with PCOD. Methodology: This prospective observational study was carried out in gynaecology department of Mallareddy hospital, where subjects were enrolled based on inclusion and exclusion criteria. All 100 patients demographics were documented. The prevalence of clinical manifestations and hormonal abnormalities in all subjects were assessed.Results: Irregular menstruation was seen as the most common clinical manifestation and seen in maximum 66% of subjects, Hirsutism was seen in 35% of the cases followed by acne in 28% of cases , androgenic alopecia in 22% of cases and acanthosis nigricans in minority 7% of cases .When the subjects were assessed for hormonal abnormalities, 52% of the subjects showed decreased FSH, 48% of the subjects had increased LH, 9% had decreased and33 % had increased PRL, 38% showed increased Testosterone, 21% had decreased and 7% had increased T3, T4 levels.Conclusion: Irregular menstruation was seen as the most common clinical manifestation followed by dermatologic manifestations –Hirsutism, Acne, Acanthosis nigricans and androgenic alopecia.Clinical manifestations diagnosis can lead to early treatment in these patients and helps them in relieving their symptoms and improve qualityof life.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一项与多囊卵巢疾病相关的临床表现和激素异常患病率的前瞻性横断面观察研究
多囊卵巢疾病(PCOD)是世界范围内生殖期女性最常见的激素失调疾病。从非常有限的数据来看,PCOD在印度的患病率从3.7%到22.5%不等。多囊卵巢疾病需要“控制”而不是“治愈”,治疗决定取决于症状、年龄、妇女是否想怀孕。目的:探讨PCOD的临床表现及激素异常的发生率。方法:本前瞻性观察性研究在Mallareddy医院妇科进行,根据纳入和排除标准纳入受试者。记录了所有100例患者的人口统计数据。评估所有受试者的临床表现和激素异常的患病率。结果:月经不调是最常见的临床表现和最高66%的受试者,多毛症被认为在35%的情况下跟着痤疮在28%的情况下,雄性脱发在22%的情况下,黑棘皮症在少数7%的情况下,当受试者评估激素异常,52%的受试者显示减少FSH, 48%的受试者LH增加,9%的人减少and33 %光杆载荷增加,显示睾酮增加38%,21%的患者T3、T4水平降低,7%的患者T3、T4水平升高。结论:月经不调是最常见的临床表现,其次是皮肤表现:多毛症、痤疮、黑棘皮症和雄激素性脱发。临床表现的诊断可以导致这些患者的早期治疗,并帮助他们缓解症状,提高生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nutraceuticals aid in managing COVID-19 Clinical Efficacy of Simhyadi Kwathalong with Shati Churnain Tamaka Shwasa (Bronchial Asthma) Formulation and evaluation of Lamivudinefloating tablets usingCarbopol & Eudragit S 100 Development and Validation of Stability Indicating Analytical Method for the Simultaneous Estimation of Netarsudil and Latanoprost by RP-HPLC Viral Infection-A Looming Catastrophe
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1